Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Source:http://linkedlifedata.com/resource/pubmed/id/17286215

Download in:

View as

General Info

PMID
17286215